Literature DB >> 33649300

COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response.

Junaid Kashir1,2, Khaled AlKattan1, Ahmed Yaqinuddin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33649300      PMCID： PMC7919252          DOI： 10.1038/s41392-021-00490-x

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  5 in total

Review 1.  Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

Authors:  Cristina João; Vir Singh Negi; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Immunol       Date:  2018-03-15       Impact factor: 5.422

2.  Can existing live vaccines prevent COVID-19?

Authors:  Konstantin Chumakov; Christine S Benn; Peter Aaby; Shyamasundaran Kottilil; Robert Gallo
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

Review 3.  High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.

Authors:  Xiaosheng Liu; Wei Cao; Taisheng Li
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

4.  Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.

Authors:  Ahmed Yaqinuddin
Journal:  Med Hypotheses       Date:  2020-06-30       Impact factor: 1.538

5.  Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.

Authors:  Ellen Shrock; Eric Fujimura; Tomasz Kula; Richard T Timms; I-Hsiu Lee; Yumei Leng; Matthew L Robinson; Brandon M Sie; Mamie Z Li; Yuezhou Chen; Jennifer Logue; Adam Zuiani; Denise McCulloch; Felipe J N Lelis; Stephanie Henson; Daniel R Monaco; Meghan Travers; Shaghayegh Habibi; William A Clarke; Patrizio Caturegli; Oliver Laeyendecker; Alicja Piechocka-Trocha; Jonathan Z Li; Ashok Khatri; Helen Y Chu; Alexandra-Chloé Villani; Kyle Kays; Marcia B Goldberg; Nir Hacohen; Michael R Filbin; Xu G Yu; Bruce D Walker; Duane R Wesemann; H Benjamin Larman; James A Lederer; Stephen J Elledge
Journal:  Science       Date:  2020-09-29       Impact factor: 63.714
  5 in total
  2 in total

1.  Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark.

Authors:  Christian Holm Hansen; Nikolaj Ulrik Friis; Peter Bager; Marc Stegger; Jannik Fonager; Anders Fomsgaard; Mie Agermose Gram; Lasse Engbo Christiansen; Steen Ethelberg; Rebecca Legarth; Tyra Grove Krause; Henrik Ullum; Palle Valentiner-Branth
Journal:  Lancet Infect Dis       Date:  2022-10-18       Impact factor: 71.421

Review 2.  A look into the future of the COVID-19 pandemic in Europe: an expert consultation.

Authors:  Emil Nafis Iftekhar; Viola Priesemann; Rudi Balling; Simon Bauer; Philippe Beutels; André Calero Valdez; Sarah Cuschieri; Thomas Czypionka; Uga Dumpis; Enrico Glaab; Eva Grill; Claudia Hanson; Pirta Hotulainen; Peter Klimek; Mirjam Kretzschmar; Tyll Krüger; Jenny Krutzinna; Nicola Low; Helena Machado; Carlos Martins; Martin McKee; Sebastian Bernd Mohr; Armin Nassehi; Matjaž Perc; Elena Petelos; Martyn Pickersgill; Barbara Prainsack; Joacim Rocklöv; Eva Schernhammer; Anthony Staines; Ewa Szczurek; Sotirios Tsiodras; Steven Van Gucht; Peter Willeit
Journal:  Lancet Reg Health Eur       Date:  2021-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.